Capital BlueCross waives virtual care fees through March

Capital BlueCross, a Pennsylvania-based insurer that covers close to 1 million members, is temporarily waiving virtual care fees through March 31, the insurer said Jan. 19.

Advertisement

The waiver means eligible members won’t have to face copays, coinsurance or deductibles for medical and mental health visits that are provided through the insurer’s telemedicine app. The app connects members to physicians, psychologists, psychiatrists and counselors.

The updates were announced with a new mobile app for Capital BlueCross members called NeuroFlow. The app offers members self-care and relaxation exercises. Capital BlueCross helped bring the app to market through the Smart Health Innovation Lab, which the insurer co-founded in 2018.

Capital BlueCross also plans to issue a mental wellness toolkit for its employer members in early 2021, which aims to offer guidance and resources for employees facing stress, anxiety and depression. 

Read more here.

More articles on payers:
UnitedHealthcare suspends some prior authorization rules for hospitals
Cigna to suspend donations to lawmakers who ‘supported violence’ at Capitol
Bill to end antitrust exemption for health insurers awaits Trump’s signature

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Telehealth

Advertisement

Comments are closed.